Investors

Invest in the Future of Modular Clinical Measurement.

A modular electrochemical measurement platform built on proprietary engineering and scalable consumables

Request Deck

Founders Note

Platform First

Engineered as a modular system built for scale, longevity, and multi-anssayexpansion.

Streamlined Output

Designed to streamline measurement workflows without reliance on external labe

Scalable test menu

A consumable driven architecture designed to support additional assays overr time.

120M+

Annual HbA1c Tests (U.S)

Distributed Infrastructure

Testing spans clinics, labs, and reference facilities.

Workflow Complexity

Multiple handoffs are common

Business Model: Razor & Blade

Corvidan follows a razor and blade model built around a durable, professional use measurement reader and single use electrochemical test strips. The reader is placed once, while consumables drive recurring usage over time.

Each test strip is assay specific and developed independently, allowing new measurements to be introduced without modifying the core device hardware. This structure supports predictable manufacturing, controlled expansion and repeatable workflows.

By separating instrumentation from consumables, Corvidan aligns long term platform adoption with recurring revenue. All while maintaining consistent measurement across use cases.

Engineering Development

2025

Analytical Bench Evaluation

Q4 2025

Workflow Validation

Q2 2026

Limited Evaluation Deployment

Q4 2026

Regulatory Preparation Milestone

Q1 2027

Join the Next Round.

Request investor materials or connect with the founding team.

Request Investor Materials